Position in PFE
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$3,784,771
-$1,398,234 QoQ
Shares Held
157,175
-14.8% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#713
of 2,821 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ascent Group, LLC holds $78,181,149 across 13 Drug Manufacturers - General names. PFE ranks #6 (4.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
18,846 | $22,604,455 | |
| 2 | JNJ |
Johnson & Johnson
|
70,352 | $17,867,294 | |
| 3 | ABBV |
AbbVie Inc.
|
35,888 | $9,030,853 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
63,356 | $8,004,392 | |
| 5 | MRK |
Merck & Co., Inc.
|
41,325 | $5,310,262 | |
| 6 | PFE |
Pfizer Inc
This page
|
157,175 | $3,784,771 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
55,716 | $3,210,352 | |
| 8 | AMGN |
Amgen Inc
|
7,847 | $2,841,552 |
All Filings in PFE
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,784,771 | 157,175 | Shares | Other | 2026-08-03 | |
| 2026-03-31 | $5,183,005 | 184,580 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $4,908,135 | 197,114 | Shares | Other | 2026-01-20 | |
| 2025-09-30 | $4,181,874 | 164,124 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $2,262,632 | 93,343 | Shares | Other | 2025-07-21 | |
| 2025-03-31 | $2,593,546 | 102,350 | Shares | Other | 2025-05-16 | |
| 2024-12-31 | $1,847,468 | 69,637 | Shares | Other | 2025-02-21 | |
| 2024-09-30 | $1,814,885 | 62,712 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,422,643 | 50,845 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $1,145,520 | 41,280 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,224,726 | 42,540 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,676,743 | 50,550 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,506,564 | 68,336 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,922,952 | 71,641 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $5,021,468 | 97,999 | Shares | Sole | 2023-02-17 | |
| 2022-09-30 | $4,297,450 | 98,205 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $4,932,299 | 94,074 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $4,840,080 | 93,492 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $5,533,752 | 93,713 | Shares | Sole | 2022-03-01 | |
| No filing history on record for this holder in this stock. | ||||||